IMI2 (Innovative Medicines Initiative) is a public-private initiative between the European Union and EFPIA (European Federation of Pharmaceutical Industries and Associations). Its purpose is to create partnerships that promote the development of drugs of the future. IMI2 has launched its 12th call, through which it will finance projects encompassed within the following lines: Topic 1:Development […]
The next 13th of July at 1.00p.m will be held the conference organized by the Department of Molecular Biology and the Faculty of Medicine of the University of Cantabria, given by Dr. Guillermo Montoya who will talk about the mechanisms of recognition and cutting of the DNA of the endonuclease of class 2 type V […]
Using different advanced microscopy techniques, a group of researchers from the REIPI network demonstrated that human neutrophils easily phagocytose and kill Acinetobacter baumannii and A. pittii. After bacteria-cell contact, neutrophils rapidly and continuously engulf and kill bacteria during at least 4 hours of infection in vitro. Also, neutrophils release neutrophil extracellular traps (NETs) against Acinetobacter. […]
IDIVAL and the University of Cantabria launch the third call for predoctoral contracts, offering 7 contracts of up to 4 years of duration for the development of doctoral thesis. The aim of this call is to promote the training of doctors in programs of solvency formative and research. This is an advertising, objectivity and competitive […]
Revista Medica Valdecilla has edited the first number of this year 2017 which is already available on the website of Marques de Valdecilla University Hospital (http://www.humv.es/revista-valdecilla/). The journal was created in 2015 with the aim of promoting and supporting research, including research developed by residents, in the environment of the public health system of Cantabria. […]
